CN104305192B - 改善老年痴呆症患者记忆的功能性食品及其制备方法 - Google Patents
改善老年痴呆症患者记忆的功能性食品及其制备方法 Download PDFInfo
- Publication number
- CN104305192B CN104305192B CN201410570388.9A CN201410570388A CN104305192B CN 104305192 B CN104305192 B CN 104305192B CN 201410570388 A CN201410570388 A CN 201410570388A CN 104305192 B CN104305192 B CN 104305192B
- Authority
- CN
- China
- Prior art keywords
- parts
- functional food
- subsequent use
- ginseng
- pseudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 41
- 208000024827 Alzheimer disease Diseases 0.000 title claims abstract description 23
- 206010039966 Senile dementia Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 19
- 239000000284 extract Substances 0.000 claims abstract description 73
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 50
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 31
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 31
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 30
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 30
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 27
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 27
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 24
- 239000003240 coconut oil Substances 0.000 claims abstract description 24
- 229940057917 medium chain triglycerides Drugs 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 241000545442 Radix Species 0.000 claims abstract description 19
- 239000006071 cream Substances 0.000 claims abstract description 19
- 239000000341 volatile oil Substances 0.000 claims abstract description 18
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract 2
- 239000007901 soft capsule Substances 0.000 claims description 32
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 25
- 210000002569 neuron Anatomy 0.000 abstract description 16
- 230000003915 cell function Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 description 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 238000010992 reflux Methods 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 206010022489 Insulin Resistance Diseases 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000013016 learning Effects 0.000 description 7
- 244000060011 Cocos nucifera Species 0.000 description 6
- 235000013162 Cocos nucifera Nutrition 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 102000003746 Insulin Receptor Human genes 0.000 description 5
- 108010001127 Insulin Receptor Proteins 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 description 5
- 229960004640 memantine Drugs 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000006386 memory function Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000009189 diving Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 241000522254 Cassia Species 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 230000000324 neuroprotective effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 2
- 229960002646 scopolamine Drugs 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229940123511 Excitatory amino acid receptor antagonist Drugs 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 238000012347 Morris Water Maze Methods 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- ZDJPJSHPGXKPBL-UHFFFAOYSA-N N=NC=NN.N=NC=NN.Cl Chemical compound N=NC=NN.N=NC=NN.Cl ZDJPJSHPGXKPBL-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- WUSAVCGXMSWMQM-UHFFFAOYSA-N ambucetamide Chemical compound CCCCN(CCCC)C(C(N)=O)C1=CC=C(OC)C=C1 WUSAVCGXMSWMQM-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003530 donepezil Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410570388.9A CN104305192B (zh) | 2014-10-23 | 2014-10-23 | 改善老年痴呆症患者记忆的功能性食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410570388.9A CN104305192B (zh) | 2014-10-23 | 2014-10-23 | 改善老年痴呆症患者记忆的功能性食品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104305192A CN104305192A (zh) | 2015-01-28 |
CN104305192B true CN104305192B (zh) | 2016-05-04 |
Family
ID=52360627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410570388.9A Active CN104305192B (zh) | 2014-10-23 | 2014-10-23 | 改善老年痴呆症患者记忆的功能性食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104305192B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106389740A (zh) * | 2016-09-13 | 2017-02-15 | 王全峰 | 一种预防和/或延缓老年轻度认知障碍的组合物及其使用方法 |
CN110051795A (zh) * | 2019-05-29 | 2019-07-26 | 郑欣桐 | 一种减缓记忆力衰退的组合物及其制备方法 |
CN112021499A (zh) * | 2020-09-02 | 2020-12-04 | 江苏经贸职业技术学院 | 适用于老年痴呆症的食品配方和制作方式 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1565524A (zh) * | 2003-07-02 | 2005-01-19 | 上海乐胜科技有限公司 | 一种治疗老年性痴呆的药物及其制备方法 |
CN1857388A (zh) * | 2006-03-17 | 2006-11-08 | 崔彬 | 三七茎叶总皂苷组合物的制备及应用 |
CN1861111A (zh) * | 2005-05-13 | 2006-11-15 | 天津天士力制药股份有限公司 | 芪参益气滴丸在制备防治老年痴呆药物中的应用 |
CN101181285A (zh) * | 2007-12-20 | 2008-05-21 | 中国人民解放军第二军医大学 | 黄芪甲苷在制备治疗神经退行性疾病药物中的应用 |
CN101742926A (zh) * | 2007-06-26 | 2010-06-16 | N.V.努特里奇亚 | 用于改善脑功能的脂质组合物 |
CN101766784A (zh) * | 2008-12-26 | 2010-07-07 | 北京天科仁祥医药科技有限公司 | 一种治疗老年性痴呆的中药颗粒剂 |
CN101809443A (zh) * | 2007-07-31 | 2010-08-18 | 艾克塞拉公司 | 基因组测试和生酮化合物用于治疗降低的认知功能的用途 |
CN102186489A (zh) * | 2008-10-07 | 2011-09-14 | 特拉维夫大学拉玛特有限公司 | 肉桂提取物用于治疗淀粉样蛋白相关疾病的应用 |
CN102240311A (zh) * | 2011-03-07 | 2011-11-16 | 昆明制药集团股份有限公司 | 三七三醇皂苷在制备预防和治疗神经退行性疾病药物中的应用 |
CN102406778A (zh) * | 2011-12-01 | 2012-04-11 | 上海市中医老年医学研究所 | 治疗阿尔茨海默型痴呆的中药组合物及其制备方法 |
CN103028109A (zh) * | 2013-01-05 | 2013-04-10 | 山东沃华医药科技股份有限公司 | 一种治疗阿尔茨海默症的中药制剂 |
CN103520147A (zh) * | 2013-07-23 | 2014-01-22 | 无限极(中国)有限公司 | 葛根素或含有葛根素的药物组合物在制备具有预防或治疗老年痴呆症作用的药物中的用途 |
-
2014
- 2014-10-23 CN CN201410570388.9A patent/CN104305192B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1565524A (zh) * | 2003-07-02 | 2005-01-19 | 上海乐胜科技有限公司 | 一种治疗老年性痴呆的药物及其制备方法 |
CN1861111A (zh) * | 2005-05-13 | 2006-11-15 | 天津天士力制药股份有限公司 | 芪参益气滴丸在制备防治老年痴呆药物中的应用 |
CN1857388A (zh) * | 2006-03-17 | 2006-11-08 | 崔彬 | 三七茎叶总皂苷组合物的制备及应用 |
CN101742926A (zh) * | 2007-06-26 | 2010-06-16 | N.V.努特里奇亚 | 用于改善脑功能的脂质组合物 |
CN101809443A (zh) * | 2007-07-31 | 2010-08-18 | 艾克塞拉公司 | 基因组测试和生酮化合物用于治疗降低的认知功能的用途 |
CN101181285A (zh) * | 2007-12-20 | 2008-05-21 | 中国人民解放军第二军医大学 | 黄芪甲苷在制备治疗神经退行性疾病药物中的应用 |
CN102186489A (zh) * | 2008-10-07 | 2011-09-14 | 特拉维夫大学拉玛特有限公司 | 肉桂提取物用于治疗淀粉样蛋白相关疾病的应用 |
CN101766784A (zh) * | 2008-12-26 | 2010-07-07 | 北京天科仁祥医药科技有限公司 | 一种治疗老年性痴呆的中药颗粒剂 |
CN102240311A (zh) * | 2011-03-07 | 2011-11-16 | 昆明制药集团股份有限公司 | 三七三醇皂苷在制备预防和治疗神经退行性疾病药物中的应用 |
CN102406778A (zh) * | 2011-12-01 | 2012-04-11 | 上海市中医老年医学研究所 | 治疗阿尔茨海默型痴呆的中药组合物及其制备方法 |
CN103028109A (zh) * | 2013-01-05 | 2013-04-10 | 山东沃华医药科技股份有限公司 | 一种治疗阿尔茨海默症的中药制剂 |
CN103520147A (zh) * | 2013-07-23 | 2014-01-22 | 无限极(中国)有限公司 | 葛根素或含有葛根素的药物组合物在制备具有预防或治疗老年痴呆症作用的药物中的用途 |
Non-Patent Citations (1)
Title |
---|
桂枝加葛根汤对神经炎症小鼠海马空间记忆、细胞因子和小胶质细胞的影响;徐颖 等;《中国实验方剂学杂志》;20130514;第19卷(第14期);186-190 * |
Also Published As
Publication number | Publication date |
---|---|
CN104305192A (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101411760B (zh) | 苹果属花楸苹果组植物的新用途 | |
CN104305192B (zh) | 改善老年痴呆症患者记忆的功能性食品及其制备方法 | |
CN101612316B (zh) | 铁皮石斛水提物在制备预防治疗高血压中风的药中的应用 | |
CN102423072A (zh) | 一种用于改善记忆的保健食品及其制备方法 | |
CN102028220B (zh) | 一种改善老年痴呆的功能性食品 | |
KR20160056554A (ko) | Compound K 성분이 강화된 홍삼농축액을 함유하는 비알코올성 지방간증의 예방 및 치료용 약제학적 조성물 및 건강기능 식품 | |
CN101856466B (zh) | 利用铁皮石斛花制备的预防治疗高血压中风的药及方法 | |
CN103083429B (zh) | 一种降血脂的中药组合物 | |
CN101978963A (zh) | 一种番荔枝内酯类提取物、其制备方法及其在抗癌及减缓癌性疼痛方面的用途 | |
CN105434802A (zh) | 一种治疗糖尿病的药物组合物及其制备方法和用途 | |
CN102613648B (zh) | 一种原生态竹锗营养液的制备方法 | |
CN1895387B (zh) | 一种治疗智力低下、安神助长的中药 | |
CN103768137A (zh) | 牛大力抗疲劳口服液及牛大力在制备抗疲劳保健品中的应用 | |
CN100446792C (zh) | 一种改善记忆的中药 | |
CN103040905A (zh) | 雪灵芝或其提取物在制备抗衰老的药物或保健食品中的用途 | |
CN101254199A (zh) | 人参皂苷Rg1与咖啡因组合物及其应用 | |
CN103251757B (zh) | 一种含冰片的复方制剂及其制备方法和应用 | |
CN101129604B (zh) | 一种降糖中药的制备方法 | |
CN105327331A (zh) | 用于治疗和预防老年痴呆的组合物及其制备方法与应用 | |
CN105770098A (zh) | 一种具有降血压的组合物及应用 | |
CN103800410A (zh) | 一种具有增强学习记忆功能的种植人参乙醇提取物 | |
CN104509855A (zh) | 一种可辅助降血糖的组合物及其制备方法 | |
CN105194352B (zh) | 一种改善学习记忆的中药组合物及其制备方法 | |
CN105360787A (zh) | 一种保健食品及其制备方法 | |
CN117018095B (zh) | 一种治疗孤独症的药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 213002, No. 10, No. 4, Heping scenic garden, Tianning District, Jiangsu, Changzhou Patentee after: Gong Yuesong Address before: 213022 a -402 room, 28-, Xin Jiang garden, Xinbei District, Jiangsu, China Patentee before: Gong Yuesong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190102 Address after: Room 903B, Block A, 66 Hexi Street, Jianye District, Nanjing City, Jiangsu Province Patentee after: Nanjing Qianhand Co-founding Biological Technology Co., Ltd. Address before: 213002 No. 4, 10 Building, Pingmeijing Huayuan, Tianning District, Changzhou City, Jiangsu Province Patentee before: Gong Yuesong |